VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078,139 | -68.7% | 249,569 | -52.2% | 0.00% | -100.0% |
| Q2 2023 | $3,443,643 | -0.7% | 522,556 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $3,469,656 | -7.1% | 510,995 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $3,736,333 | -50.5% | 505,593 | -33.8% | 0.00% | -50.0% |
| Q3 2022 | $7,544,000 | +12.3% | 763,605 | +23.8% | 0.00% | 0.0% |
| Q2 2022 | $6,720,000 | -53.5% | 616,591 | -51.8% | 0.00% | -33.3% |
| Q1 2022 | $14,467,000 | -37.3% | 1,279,155 | -13.0% | 0.00% | -25.0% |
| Q4 2021 | $23,065,000 | +4.4% | 1,469,966 | +14.0% | 0.00% | 0.0% |
| Q3 2021 | $22,102,000 | -6.0% | 1,289,529 | +18.0% | 0.00% | -20.0% |
| Q2 2021 | $23,504,000 | +167.3% | 1,092,698 | +86.7% | 0.01% | +150.0% |
| Q1 2021 | $8,792,000 | +15.4% | 585,315 | +0.9% | 0.00% | 0.0% |
| Q4 2020 | $7,621,000 | +30.3% | 579,932 | -4.2% | 0.00% | +100.0% |
| Q3 2020 | $5,847,000 | -18.0% | 605,238 | -2.9% | 0.00% | -50.0% |
| Q2 2020 | $7,134,000 | +14.7% | 623,590 | +3.8% | 0.00% | 0.0% |
| Q1 2020 | $6,221,000 | -38.1% | 600,559 | -2.0% | 0.00% | -33.3% |
| Q4 2019 | $10,058,000 | +25.0% | 612,894 | +1.2% | 0.00% | +50.0% |
| Q3 2019 | $8,044,000 | -4.1% | 605,789 | +1.8% | 0.00% | 0.0% |
| Q2 2019 | $8,385,000 | -24.5% | 595,073 | -1.5% | 0.00% | -33.3% |
| Q1 2019 | $11,111,000 | -32.8% | 603,920 | -4.6% | 0.00% | -40.0% |
| Q4 2018 | $16,537,000 | +22.0% | 632,889 | +7.1% | 0.01% | +66.7% |
| Q3 2018 | $13,556,000 | +231.9% | 590,671 | +175.5% | 0.00% | +200.0% |
| Q2 2018 | $4,084,000 | +18.5% | 214,370 | +4.8% | 0.00% | 0.0% |
| Q1 2018 | $3,447,000 | +13.2% | 204,574 | +2.1% | 0.00% | 0.0% |
| Q4 2017 | $3,045,000 | -14.8% | 200,361 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $3,573,000 | +11.7% | 199,578 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $3,199,000 | +22.9% | 196,273 | +5.6% | 0.00% | 0.0% |
| Q1 2017 | $2,603,000 | -12.2% | 185,942 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,965,000 | +1.0% | 185,893 | +5.4% | 0.00% | 0.0% |
| Q3 2016 | $2,936,000 | +34.7% | 176,414 | -9.4% | 0.00% | 0.0% |
| Q2 2016 | $2,179,000 | +30.9% | 194,796 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $1,665,000 | -4.6% | 199,244 | +6.2% | 0.00% | 0.0% |
| Q4 2015 | $1,746,000 | -25.2% | 187,586 | -9.4% | 0.00% | 0.0% |
| Q3 2015 | $2,335,000 | -20.6% | 206,994 | -10.7% | 0.00% | 0.0% |
| Q2 2015 | $2,940,000 | +43.2% | 231,736 | +5.0% | 0.00% | 0.0% |
| Q1 2015 | $2,053,000 | -33.0% | 220,731 | +3.2% | 0.00% | 0.0% |
| Q4 2014 | $3,063,000 | -54.8% | 213,895 | -67.3% | 0.00% | -50.0% |
| Q3 2014 | $6,783,000 | -68.0% | 653,548 | -50.1% | 0.00% | -33.3% |
| Q2 2014 | $21,202,000 | +154.6% | 1,310,266 | +155.7% | 0.00% | +50.0% |
| Q1 2014 | $8,326,000 | +271.5% | 512,461 | +183.8% | 0.00% | +100.0% |
| Q4 2013 | $2,241,000 | -60.1% | 180,589 | -64.8% | 0.00% | 0.0% |
| Q3 2013 | $5,614,000 | +332.5% | 512,712 | +219.2% | 0.00% | – |
| Q2 2013 | $1,298,000 | – | 160,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |